Current Rating Overview
MarketsMOJO’s 'Hold' rating for Jubilant Ingrevia Ltd indicates a balanced outlook for investors, suggesting that the stock is fairly valued at present and may offer moderate returns relative to its risk profile. This rating is supported by a composite Mojo Score of 64.0, reflecting a notable improvement from the previous score of 48. The upgrade to 'Hold' from 'Sell' on 08 June 2026 signals that the company’s recent developments and financial health have stabilised, warranting a neutral stance rather than a negative one.
Quality Assessment
As of 04 July 2026, Jubilant Ingrevia’s quality grade is assessed as average. The company demonstrates a strong ability to service its debt, with a low Debt to EBITDA ratio of 1.40 times, indicating manageable leverage and financial discipline. Additionally, the debt-equity ratio stands at a conservative 0.25 times, underscoring a solid capital structure that reduces financial risk. However, the company’s long-term growth metrics reveal challenges, with net sales declining at an annualised rate of -2.96% and operating profit contracting by -13.79% over the past five years. These figures suggest that while the company maintains operational stability, growth prospects remain subdued.
Valuation Considerations
Jubilant Ingrevia’s valuation is currently attractive, supported by a Return on Capital Employed (ROCE) of 10.5%, which is a reasonable indicator of efficient capital utilisation. The Enterprise Value to Capital Employed ratio is 3.1, signalling that the stock is trading at a discount relative to its peers’ historical valuations. Despite the stock’s 1-year return of -12.74%, the company’s profits have increased by 14.4% over the same period, reflecting improving operational profitability. The Price/Earnings to Growth (PEG) ratio of 2.6 suggests that the stock’s valuation is somewhat stretched relative to its earnings growth, but not excessively so, justifying the 'Hold' stance.
Financial Trend Analysis
The financial trend for Jubilant Ingrevia is positive as of 04 July 2026. Quarterly net sales reached a high of ₹1,178.65 crores, indicating recent revenue strength. The company’s operating profit to interest coverage ratio is robust at 13.77 times, highlighting strong earnings relative to interest expenses and reinforcing financial stability. Institutional investors hold a significant 31.27% stake in the company, with their holdings increasing by 1.1% in the previous quarter. This growing institutional interest often reflects confidence in the company’s fundamentals and outlook.
Technical Outlook
From a technical perspective, Jubilant Ingrevia exhibits a mildly bullish trend. The stock has delivered positive short-term returns, with gains of 1.62% in the last day, 9.74% over the past week, and 17.77% in the last three months. However, it has underperformed over longer periods, with a 6-month return of -6.16% and a year-to-date decline of -3.13%. The one-year return of -12.74% also trails the broader BSE500 index, which itself declined by -1.25% over the same timeframe. This mixed technical performance supports a cautious approach, consistent with the 'Hold' rating.
Implications for Investors
For investors, the 'Hold' rating on Jubilant Ingrevia Ltd suggests maintaining existing positions rather than initiating new ones or exiting holdings. The company’s stable financial position, attractive valuation, and improving profitability provide a foundation for potential future gains. However, the subdued long-term growth and recent underperformance relative to the market counsel prudence. Investors should monitor upcoming quarterly results and sector developments closely to reassess the stock’s outlook.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Sector and Market Context
Operating within the Specialty Chemicals sector, Jubilant Ingrevia faces competitive pressures and cyclical demand patterns. The sector’s dynamics often influence valuation multiples and growth trajectories. Compared to its peers, Jubilant Ingrevia’s current discount valuation and improving profit margins may offer a relative advantage. However, investors should remain aware of sector-specific risks such as raw material price volatility and regulatory changes that could impact future earnings.
Summary of Key Metrics as of 04 July 2026
To summarise, the stock’s key financial and market metrics include:
- Mojo Score: 64.0 (Hold grade)
- Debt to EBITDA ratio: 1.40 times
- Debt-Equity ratio: 0.25 times
- ROCE: 10.5%
- Enterprise Value to Capital Employed: 3.1
- Operating Profit to Interest Coverage: 13.77 times
- Net Sales (Quarterly high): ₹1,178.65 crores
- Institutional Holdings: 31.27%, increased by 1.1% last quarter
- Stock Returns: 1D +1.62%, 1W +9.74%, 1M +8.25%, 3M +17.77%, 6M -6.16%, YTD -3.13%, 1Y -12.74%
Conclusion
Jubilant Ingrevia Ltd’s current 'Hold' rating reflects a nuanced view of the company’s financial health, valuation, and market performance as of 04 July 2026. While the company exhibits strengths in debt management and profitability, its long-term growth challenges and recent market underperformance temper enthusiasm. Investors are advised to maintain their holdings and watch for further developments that could influence the stock’s trajectory.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
